Jakob R Passweg

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

Bob Löwenberg, Carlos Graux, Nancy Boeckx, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants

John P Klein, Irwin Walker, J. Klein, 2004, British journal of haematology.

A gain-of-function mutation of JAK2 in myeloproliferative disorders.

Mario Cazzola, Robert Kralovics, M. Cazzola, 2005, The New England journal of medicine.